(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

French AI startup Mistral unveils a breakthrough 24B parameter language model that matches the performance of models three ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Nifty 50 was trading at 23249.50 (0.37%). Today Nifty 50 has been trading in the range of 23322.05 to 23139.20. Nifty futures ...

Gaming mergers and acquisitions (M&A) and financings in 2024 grew 39% to $27.3 billion in disclosed deal value across over 967 transactions, according to a report by Drake Star Partners. That’s a ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Bally's announced a $250 million public offering last month for shares of their massive Chicago casino project, but only to women or people of color. That's according to terms of the company's ...

When US tech stocks were crushed by the emergence of DeepSeek this week, already-cautious investors found one more reason to ...

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...

Revenues reached AED 14.44 billion in financial year 2024, up 82% year-on-year. Net profit for the year rose 80% year-on-year ...

Gross profit of $6.3 million, up 27.5% and net income of $4.3 million, up 34.4%, both reaching a historical high since 2022 ...